{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:38:04Z","timestamp":1789177084394,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:00:00Z","timestamp":1568332800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:00:00Z","timestamp":1568332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","award":["BIO2014-52655-R"],"award-info":[{"award-number":["BIO2014-52655-R"]}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["BIO2017-84702-R"],"award-info":[{"award-number":["BIO2017-84702-R"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PI13\/0234"],"award-info":[{"award-number":["PI13\/0234"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007801","name":"Fundaci\u00f3n S\u00e9neca","doi-asserted-by":"publisher","award":["19400\/PI\/14"],"award-info":[{"award-number":["19400\/PI\/14"]}],"id":[{"id":"10.13039\/100007801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Skin cutaneous melanoma (SKCM) is the most lethal form of skin cancer and while incidence rates are declining for most cancers, they have been steadily rising for SKCM. Serine protease inhibitor, kunitz-type, 1 (SPINT1) is a type II transmembrane serine protease inhibitor that has been shown to be involved in the development of several types of cancer, such as squamous cell carcinoma and colorectal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used the unique advantages of the zebrafish to model the impact of Spint1a deficiency in early transformation, progression and metastatic invasion of SKCM together with in silico analysis of the occurrence and relevance of SPINT1 genetic alterations of the SKCM TCGA cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We report here a high prevalence of\n                      <jats:italic>SPINT1<\/jats:italic>\n                      genetic alterations in SKCM patients and their association with altered tumor immune microenvironment and poor patient survival. The zebrafish model reveals that Spint1a deficiency facilitates oncogenic transformation, regulates the tumor immune microenvironment crosstalk, accelerates the onset of SKCM and promotes metastatic invasion. Notably, Spint1a deficiency is required at both cell autonomous and non-autonomous levels to enhance invasiveness of SKCM.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results reveal a novel therapeutic target for SKCM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-019-1389-3","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T03:03:46Z","timestamp":1568343826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Zebrafish modeling reveals that SPINT1 regulates the aggressiveness of skin cutaneous melanoma and its crosstalk with tumor immune microenvironment"],"prefix":"10.1186","volume":"38","author":[{"given":"Elena","family":"G\u00f3mez-Abenza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Ib\u00e1\u00f1ez-Molero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Garc\u00eda-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard I.","family":"Zon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Mione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda L.","family":"Cayuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Gabellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9527-0211","authenticated-orcid":false,"given":"Victoriano","family":"Mulero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,13]]},"reference":[{"key":"1389_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fcell.2016.00033","volume":"4","author":"C Wellbrock","year":"2016","unstructured":"Wellbrock C, Arozarena I. The complexity of the ERK\/MAP-kinase pathway and the treatment of melanoma skin cancer. Front Cell Dev Biol. 2016;4:33.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"1389_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nrclinonc.2013.246","volume":"11","author":"D Schadendorf","year":"2014","unstructured":"Schadendorf D, Hauschild A. Melanoma in 2013: melanoma--the run of success continues. Nat Rev Clin Oncol. 2014;11(2):75\u20136.","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"1389_CR3","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/pcmr.12592","volume":"30","author":"E van Rooijen","year":"2017","unstructured":"van Rooijen E, Fazio M, Zon LI. From fish bowl to bedside: the power of zebrafish to unravel melanoma pathogenesis and discover new therapeutics. Pigment Cell Melanoma Res. 2017;30(4):402\u201312.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1389_CR4","unstructured":"NIH. Cancer stat facts: melanoma of the skin: National Cancer Institute; 2019. \n                    https:\/\/seer.cancer.gov\/statfacts\/html\/melan.html"},{"key":"1389_CR5","doi-asserted-by":"publisher","first-page":"15003","DOI":"10.1038\/nrdp.2015.3","volume":"1","author":"D Schadendorf","year":"2015","unstructured":"Schadendorf D, Fisher DE, Garbe C, Gershenwald JE, Grob JJ, Halpern A, et al. Melanoma. Nat Rev Dis Primers. 2015;1:15003.","journal-title":"Nat Rev Dis Primers"},{"key":"1389_CR6","doi-asserted-by":"publisher","first-page":"571087","DOI":"10.1155\/2012\/571087","volume":"2012","author":"JD Hoerter","year":"2012","unstructured":"Hoerter JD, Bradley P, Casillas A, Chambers D, Weiswasser B, Clements L, et al. Does melanoma begin in a melanocyte stem cell? J Skin Cancer. 2012;2012:571087.","journal-title":"J Skin Cancer"},{"issue":"6272","key":"1389_CR7","doi-asserted-by":"publisher","first-page":"aad2197","DOI":"10.1126\/science.aad2197","volume":"351","author":"CK Kaufman","year":"2016","unstructured":"Kaufman CK, Mosimann C, Fan ZP, Yang S, Thomas AJ, Ablain J, et al. A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation. Science. 2016;351(6272):aad2197.","journal-title":"Science"},{"issue":"12","key":"1389_CR8","doi-asserted-by":"publisher","first-page":"e15170","DOI":"10.1371\/journal.pone.0015170","volume":"5","author":"C Santoriello","year":"2010","unstructured":"Santoriello C, Gennaro E, Anelli V, Distel M, Kelly A, Koster RW, et al. Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish. PLoS One. 2010;5(12):e15170.","journal-title":"PLoS One"},{"issue":"2","key":"1389_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2217\/mmt.15.4","volume":"2","author":"N Nguyen","year":"2015","unstructured":"Nguyen N, Couts KL, Luo Y, Fujita M. Understanding melanoma stem cells. Melanoma Manag. 2015;2(2):179\u201388.","journal-title":"Melanoma Manag"},{"issue":"9","key":"1389_CR10","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1172\/JCI80007","volume":"125","author":"S Shalapour","year":"2015","unstructured":"Shalapour S, Karin M. Immunity, inflammation, and cancer: an eternal fight between good and evil. J Clin Invest. 2015;125(9):3347\u201355.","journal-title":"J Clin Invest"},{"key":"1389_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/978-3-0348-0837-8_17","volume":"816","author":"GB Maru","year":"2014","unstructured":"Maru GB, Gandhi K, Ramchandani A, Kumar G. The role of inflammation in skin cancer. Adv Exp Med Biol. 2014;816:437\u201369.","journal-title":"Adv Exp Med Biol"},{"key":"1389_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5334\/1750-2187-11-2","volume":"11","author":"L Tang","year":"2016","unstructured":"Tang L, Wang K. Chronic inflammation in skin malignancies. J Mol Signal. 2016;11:2.","journal-title":"J Mol Signal"},{"issue":"26","key":"1389_CR13","doi-asserted-by":"publisher","first-page":"18231","DOI":"10.1074\/jbc.274.26.18231","volume":"274","author":"CY Lin","year":"1999","unstructured":"Lin CY, Anders J, Johnson M, Sang QA, Dickson RB. Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J Biol Chem. 1999;274(26):18231\u20136.","journal-title":"J Biol Chem"},{"issue":"5","key":"1389_CR14","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1046\/j.1432-1327.2001.02016.x","volume":"268","author":"C Benaud","year":"2001","unstructured":"Benaud C, Dickson RB, Lin CY. Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. Eur J Biochem. 2001;268(5):1439\u201347.","journal-title":"Eur J Biochem"},{"issue":"2","key":"1389_CR15","doi-asserted-by":"publisher","first-page":"C423","DOI":"10.1152\/ajpcell.00164.2008","volume":"295","author":"IC Tseng","year":"2008","unstructured":"Tseng IC, Chou FP, Su SF, Oberst M, Madayiputhiya N, Lee MS, et al. Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1. Am J Physiol Cell Physiol. 2008;295(2):C423\u201331.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"10","key":"1389_CR16","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1074\/jbc.272.10.6370","volume":"272","author":"T Shimomura","year":"1997","unstructured":"Shimomura T, Denda K, Kitamura A, Kawaguchi T, Kito M, Kondo J, et al. Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem. 1997;272(10):6370\u20136.","journal-title":"J Biol Chem"},{"issue":"16","key":"1389_CR17","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1101\/gad.1300705","volume":"19","author":"K List","year":"2005","unstructured":"List K, Szabo R, Molinolo A, Sriuranpong V, Redeye V, Murdock T, et al. Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes Dev. 2005;19(16):1934\u201350.","journal-title":"Genes Dev"},{"issue":"1","key":"1389_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2217\/14796694.5.1.97","volume":"5","author":"K List","year":"2009","unstructured":"List K. Matriptase: a culprit in cancer? Future Oncol. 2009;5(1):97\u2013104.","journal-title":"Future Oncol"},{"issue":"Pt 19","key":"1389_CR19","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1242\/jcs.009159","volume":"120","author":"JR Mathias","year":"2007","unstructured":"Mathias JR, Dodd ME, Walters KB, Rhodes J, Kanki JP, Look AT, et al. Live imaging of chronic inflammation caused by mutation of zebrafish Hai1. J Cell Sci. 2007;120(Pt 19):3372\u201383.","journal-title":"J Cell Sci"},{"issue":"19","key":"1389_CR20","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1242\/dev.004556","volume":"134","author":"TJ Carney","year":"2007","unstructured":"Carney TJ, von der Hardt S, Sonntag C, Amsterdam A, Topczewski J, Hopkins N, et al. Inactivation of serine protease Matriptase1a by its inhibitor Hai1 is required for epithelial integrity of the zebrafish epidermis. Development. 2007;134(19):3461\u201371.","journal-title":"Development"},{"key":"1389_CR21","volume-title":"The zebrafish book. A guide for the laboratory use of zebrafish Danio* (Brachydanio) rerio","author":"M Westerfield","year":"2000","unstructured":"Westerfield M. The zebrafish book. A guide for the laboratory use of zebrafish Danio* (Brachydanio) rerio. Eugene: University of Oregon Press; 2000."},{"issue":"2","key":"1389_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.stem.2007.11.002","volume":"2","author":"RM White","year":"2008","unstructured":"White RM, Sessa A, Burke C, Bowman T, LeBlanc J, Ceol C, et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell. 2008;2(2):183\u20139.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"1389_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1242\/dmm.024166","volume":"9","author":"M Dang","year":"2016","unstructured":"Dang M, Henderson RE, Garraway LA, Zon LI. Long-term drug administration in the adult zebrafish using oral gavage for cancer preclinical studies. Dis Model Mech. 2016;9(7):811\u201320.","journal-title":"Dis Model Mech"},{"key":"1389_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2407-9-128","volume":"9","author":"IJ Marques","year":"2009","unstructured":"Marques IJ, Weiss FU, Vlecken DH, Nitsche C, Bakkers J, Lagendijk AK, et al. Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer. 2009;9:128.","journal-title":"BMC Cancer"},{"issue":"9","key":"1389_CR25","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45.","journal-title":"Nucleic Acids Res"},{"issue":"6917","key":"1389_CR26","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860\u20137.","journal-title":"Nature"},{"issue":"7519","key":"1389_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio OR, Chu NQ, Szabo AL, Chu T, Rhebergen AM, Jairam V, et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 2014;513(7519):559\u201363.","journal-title":"Nature"},{"issue":"7655","key":"1389_CR28","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon SR, Maute RL, Dulken BW, Hutter G, George BM, McCracken MN, et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017;545(7655):495\u20139.","journal-title":"Nature"},{"issue":"7331","key":"1389_CR29","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nature09666","volume":"469","author":"MR Zaidi","year":"2011","unstructured":"Zaidi MR, Davis S, Noonan FP, Graff-Cherry C, Hawley TS, Walker RL, et al. Interferon-gamma links ultraviolet radiation to melanomagenesis in mice. Nature. 2011;469(7331):548\u201353.","journal-title":"Nature"},{"issue":"3","key":"1389_CR30","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s12032-013-0648-y","volume":"30","author":"L Ronnstrand","year":"2013","unstructured":"Ronnstrand L, Phung B. Enhanced SOX10 and KIT expression in cutaneous melanoma. Med Oncol. 2013;30(3):648.","journal-title":"Med Oncol"},{"issue":"2","key":"1389_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.humpath.2013.02.007","volume":"45","author":"NG Ordonez","year":"2014","unstructured":"Ordonez NG. Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update. Hum Pathol. 2014;45(2):191\u2013205.","journal-title":"Hum Pathol"},{"issue":"7","key":"1389_CR32","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1080\/21645515.2017.1312043","volume":"13","author":"H Wang","year":"2017","unstructured":"Wang H, Yang L, Wang D, Zhang Q, Zhang L. Pro-tumor activities of macrophages in the progression of melanoma. Hum Vaccin Immunother. 2017;13(7):1556\u201362.","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"1389_CR33","doi-asserted-by":"publisher","first-page":"e1000562","DOI":"10.1371\/journal.pbio.1000562","volume":"8","author":"Y Feng","year":"2010","unstructured":"Feng Y, Santoriello C, Mione M, Hurlstone A, Martin P. Live imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammation. PLoS Biol. 2010;8(12):e1000562.","journal-title":"PLoS Biol"},{"key":"1389_CR34","doi-asserted-by":"publisher","unstructured":"Carreau N, Pavlick A. Revolutionizing treatment of advanced melanoma with immunotherapy. Surg Oncol. 2019. \n                    https:\/\/doi.org\/10.1016\/j.suronc.2019.01.002\n                    \n                  .","DOI":"10.1016\/j.suronc.2019.01.002"},{"issue":"17","key":"1389_CR35","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.15252\/embj.201490147","volume":"34","author":"N Antonio","year":"2015","unstructured":"Antonio N, Bonnelykke-Behrndtz ML, Ward LC, Collin J, Christensen IJ, Steiniche T, et al. The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer. EMBO J. 2015;34(17):2219\u201336.","journal-title":"EMBO J"},{"issue":"6","key":"1389_CR36","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/ijc.28551","volume":"134","author":"J Jablonska","year":"2014","unstructured":"Jablonska J, Wu CF, Andzinski L, Leschner S, Weiss S. CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-beta. Int J Cancer. 2014;134(6):1346\u201358.","journal-title":"Int J Cancer"},{"issue":"7","key":"1389_CR37","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1158\/1078-0432.CCR-08-2387","volume":"15","author":"S Singh","year":"2009","unstructured":"Singh S, Sadanandam A, Nannuru KC, Varney ML, Mayer-Ezell R, Bond R, et al. Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis. Clin Cancer Res. 2009;15(7):2380\u20136.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1389_CR38","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ijc.31075","volume":"142","author":"C Gabellini","year":"2018","unstructured":"Gabellini C, Gomez-Abenza E, Ibanez-Molero S, Tupone MG, Perez-Oliva AB, de Oliveira S, et al. Interleukin 8 mediates bcl-xL-induced enhancement of human melanoma cell dissemination and angiogenesis in a zebrafish xenograft model. Int J Cancer. 2018;142(3):584\u201396.","journal-title":"Int J Cancer"},{"issue":"14","key":"1389_CR39","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1016\/j.ejca.2009.07.007","volume":"45","author":"C Gabellini","year":"2009","unstructured":"Gabellini C, Trisciuoglio D, Desideri M, Candiloro A, Ragazzoni Y, Orlandi A, et al. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression. Eur J Cancer. 2009;45(14):2618\u201327.","journal-title":"Eur J Cancer"},{"issue":"42","key":"1389_CR40","doi-asserted-by":"publisher","first-page":"68614","DOI":"10.18632\/oncotarget.11863","volume":"7","author":"M Kawaguchi","year":"2016","unstructured":"Kawaguchi M, Yamamoto K, Kanemaru A, Tanaka H, Umezawa K, Fukushima T, et al. Inhibition of nuclear factor-kappaB signaling suppresses Spint1-deletion-induced tumor susceptibility in the ApcMin\/+ model. Oncotarget. 2016;7(42):68614\u201322.","journal-title":"Oncotarget"},{"issue":"1","key":"1389_CR41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/cas.12306","volume":"105","author":"J Ye","year":"2014","unstructured":"Ye J, Kawaguchi M, Haruyama Y, Kanemaru A, Fukushima T, Yamamoto K, et al. Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model. Cancer Sci. 2014;105(1):44\u201351.","journal-title":"Cancer Sci"},{"issue":"1","key":"1389_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1755-148X.2007.00433.x","volume":"21","author":"DC Bennett","year":"2008","unstructured":"Bennett DC. How to make a melanoma: what do we know of the primary clonal events? Pigment Cell Melanoma Res. 2008;21(1):27\u201338.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"7","key":"1389_CR43","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1158\/0008-5472.CAN-06-3481","volume":"67","author":"SR Alonso","year":"2007","unstructured":"Alonso SR, Tracey L, Ortiz P, Perez-Gomez B, Palacios J, Pollan M, et al. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res. 2007;67(7):3450\u201360.","journal-title":"Cancer Res"},{"issue":"12","key":"1389_CR44","doi-asserted-by":"publisher","first-page":"6449","DOI":"10.21873\/anticanres.11243","volume":"36","author":"S Yan","year":"2016","unstructured":"Yan S, Holderness BM, Li Z, Seidel GD, Gui J, Fisher JL, et al. Epithelial-mesenchymal expression phenotype of primary melanoma and matched metastases and relationship with overall survival. Anticancer Res. 2016;36(12):6449\u201356.","journal-title":"Anticancer Res"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-019-1389-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T19:11:24Z","timestamp":1599851484000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-019-1389-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,13]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1389"],"URL":"https:\/\/doi.org\/10.1186\/s13046-019-1389-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/611145","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,13]]},"assertion":[{"value":"30 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experiments complied with the Guidelines of the European Union Council (Directive 2010\/63\/EU) and the Spanish RD 53\/2013. Experiments and procedures were performed as approved by the Consejer\u00eda de Agua, Agricultura, Ganader\u00eda y Pesca de la CARM (authorization number # A13180602).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"L.I.Z. is a founder and stockholder of Fate Therapeutics, Inc., Scholar Rock and Camp4 Therapeutics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"405"}}